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of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumed.2Methods: The syntheses of complexes of coumarin ana-
logues were accomplished by mixing a hydro-alcoholic
solution of 3-aryl-azo-4-hydroxy coumarin analogues
with transition metal chlorides. The structural environ-
ment of the synthesized molecules was characterized us-
ing different instrumental methods. The antimicrobial
activity of the compounds was determined by the agar
well diffusion method.
Results: The cobalt complexes of (E)-3-((4-chlorophenyl)
diazenyl)-4-hydroxy-2H-chromen-2-one (HL1): (4a) and
(E)-3-((4-methoxyphenyl) diazenyl)-4-hydroxy-2H-chro-
men-2-one (HL2): (4e) showed excellent antimicrobial
activities compared with their ligands.
Conclusion: The reports of the antimicrobial investiga-
tion showed that the cobalt complexes of 3-aryl-azo-4-
hydroxy coumarin analogues exhibited potential antimi-
crobial activity that was stronger than that of their
ligands.
Keywords: Antimicrobial activity; Cobalt complexes;
Coumarin analogues; Transitional metal complexes
 2016 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Due to the increasing number of multi-drug-resistant mi-
crobial pathogens and the inclusion of emerging infectioushis is an open access article under the CC BY-NC-ND license
16/j.jtumed.2016.10.004
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J. Sahoo and S.K. Paidesetty2diseases such as severe acute respiratory syndrome and avian
influenza, the treatment of microbial infections still remains a
challenging job with the available antimicrobials and remains
a worldwide problem for clinical management.1 Development
of newer molecules with less expense and minimum toxicity
for the management of infections due to multi-drug-
resistant (MDR) microbial pathogens should represent the
vital sphere of antimicrobial research today. A literature
survey revealed that azo molecules are popular for versatile
uses such as antiseptics,2 antimicrobial,3 antidiabetics,4
antineoplastics,5 transmissible spongiform encephalopathy,6
antiulcerative,7 antoxidant,8 analgesic,9 antiinflammatory,10
antiviral,11 antitubercular10 and antitumour12 activities.
A literature survey also revealed that azo-bearing ligands
have a modified therapeutic effect when combined with
transition metal ions.13,14 The complexes of transition metals
have significant biological functions including antibacterial,
antifungal and anticancer activities.15 Cobalt, copper,
nickel and zinc are the potentially used metal ions that
form low-molecular-weight complexes, which are found to
be effective against various diseases. Literature support even
suggests that metal complexes are more active than their li-
gands because the metal complexes serve as a vehicle for
activation of the ligands as principal cytotoxic species.16,17
The biological aspects of metallic ligands depend upon the
ease of cleaving the bond between the metal ion and the
ligand. It is well known that the metals present in complexes
generally accelerate the drug action and the efficacy of
therapeutic agents and that the pharmacological efficiencies
of drug-based metal complexes depend upon the nature of
the metal ion and the ligands.18 The present work is the
continuation of our previously reported work to obtain
some novel complexes where the 4-chlorophenyl and 4-
methoxyphenyl substituted 4-hydroxycumarin azo-
analogues are conjugated with different transitional metals
with an intention to produce target molecules possessing
good antimicrobial properties.3,19Materials and Methods
All the chemicals used in the present studies were of
synthetic grade and were obtained from Merck specialties
Ltd. and HiMedia laboratories Pvt. Ltd, (Mumbai, India).
The prepared products were analysed by FT/IR (JASCO
FT/IR 4100 Spectrophotometer) using KBr pellets. An
LC-MS column C6 (150 mm  4.6 mm) with a 5 mm par-
ticle size (Shimadzu-Mass spectrophotometer) was used.
The 1H NMR spectra were recorded on a Bruker 1H NMR
400 MHz using tetramethylsilane as an internal standard,
and the chemical shifts were reported in d ppm. The UV
(Jasco V-630 Spectrophotometer) and elemental analyses
for C, H, N and S were performed on a Perkin Elmer
model 2400 CHNS/O analyser. A Shimadzu XRD 7000
was used for the study of the structural environment of the
synthesized ligands and their metal complexes. The
Faraday balance technique was employed for the mea-
surement of magnetic susceptibility of the metal com-
plexes. The in vitro antimicrobial activities against different
bacterial and fungal pathogens were determined by the
agar well diffusion method, sourced from IMTECH, India,
Chandigarh.Please cite this article in press as: Sahoo J, Paidesetty SK, Antimicrobial activity
of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumSynthesis of ligands (3ae3b)
The synthetic procedures yielding the ligands (E)-3-((4-
chlorophenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (HL1):
(3a) and (E)-3-((4-methoxyphenyl) diazenyl)-4-hydroxy-2H-
chromen-2-one (HL2): (3b) were carried out as described
previously.3
Synthesis procedure of metal complexes (4ae4h)20
A mixture of 25 mL was prepared with the appropriate
metal chloride (Cu(II), Ni(II), Co(II) and Zn(II) of 10 mmol
in ethanol and water, 1:1). The above mixture was added to
the solution of azo compound 3ae3b (0.40 g, 10 mmol) in
ethanol and water in equal proportions to obtain 50 mL of
solution. The resulting solution was refluxed for 30 min at a
controlled temperature not more than 78 C. The precipi-
tated complexes were separated by filtration using Whatman
filter paper. Separated precipitates were washed with 1:1
ethanol-water. Finally, obtained products were re-
crystallized from diethyl ether and air dried.
Spectral characterization
(E)-3-((4-chlorophenyl)diazenyl)-4-hydroxy-2H-chromen-2-one
(HL1), (3a)
Off yellow-coloured powder; yield 91%; Rf: 0.7; m.p.:
235e40 C; UVeVis (l max, DMSO): 409 nm; IR (KBr, n,
cm1): 3445(OeH str.), 1619 (C]C str.), 1500 (eN]Ne),
1726 (C]O str.), 1298 (]CeO str.), 828 (1, 4 disubst. Ar.);
1H NMR (DMSO-d6, d ppm, 400 MHz): 16.86 (s, 1H, 4-
enolic OH), 7.65 (m, coumarin H-7), 7.45 (m, coumarin H-
6), 7.47 (d, coumarin H-8), 7.90 (d, coumarin H-5), 7.21e
7.39 (m, 4H, AreH); LC-MS (RT, % area); 2.291, 60.04m/z;
301.2 (Mþ1); Analysis for C15H9ClN2O3: Calcd: C, 59.91; H,
3.02; N, 9.32; Found: C, 59.93; H, 3.04; N, 9.36%.
(E)-3-((4-methoxyphenyl)diazenyl)-4-hydroxy-2H-chromen-2-one
(HL2), (3b)
Brick red-coloured powder; yield 93%; Rf: 0.8; m.p.:
205e10 C; UVeVis (l max, DMSO): 413 nm; IR (KBr,
n, cm1): 3479 (OeH str.), 2929 (CH2 str.), 1603 (C]C
str.), 1745 (eC]O str.), 1505 (eN]Ne), 1487, 1113
(]CeOeCH3 str), 1246 (]CeO str.), 758 (1, 2 disubst.
Ar.); 1H NMR (DMSO-d6, d ppm, 400 MHz): 16.81 (s,
1H, 4-enolic OH), 7.65 (m, coumarin H-7), 7.46 (m,
coumarin H-6), 8.09 (d, coumarin H-5), 7.57 (d,
coumarin H-8), 6.94e7.34 (d, 4H, AreH), 3.83 (s, 3H,
AreOCH3); LC-MS (RT, % area); 2.291, 60.04 m/z;
297.0 (Mþ1); Analysis for C16H12N2O4: Calcd: C, 64.86;
H, 4.08; N, 9.46; Found: C, 64.91; H, 4.11; N, 9.43%.
Nickel complex of (E)-3-((4-chlorophenyl)diazenyl)-4-hydroxy-
2H-chromen-2-one (HL1), (4b)
Light green-coloured powder; yield 37%; Rf: 0.8; m.p.:
245e50 C; UVeVis (l max, DMSO): 440 nm; IR (KBr, n,
cm1): 1625 (C]C str.), 1529 (eN]Ne), 1723 (C]O str.),
1299 (]CeO str.), 829 (1, 4 disubst. Ar.), 446 (NieN), 535
(NieO); 1H NMR (DMSO-d6, d ppm, 400 MHz): 7.71 (m,
coumarin H-7), 7.36 (m, coumarin H-6), 7.38 (d, coumarin
H-8), 8.11 (d, coumarin H-5), 7.26e7.33 {m, 8H, (C6H4)2;of novel synthesized coumarin based transitional metal complexes, Journal
ed.2016.10.004
Antimicrobial assay of some metal complexes 3LC-MS (RT, % area); 1.147, 63.31 m/z; 654.01 (Mþ1);
Analysis for C32H24ClN4NiO6: Calcd: C, 58.70; H, 3.69; N,
8.56; Ni, 8.56 Found: C, 58.68; H, 3.72; N, 8.58; Ni, 8.54%.
Cobalt complex of (E)-3-((4-methoxyphenyl)diazenyl)-4-hydroxy-
2H-chromen-2-one (HL2), (4e)
Brown-coloured powder; yield 43%; Rf: 0.7; m.p.: 245e
50 C; UVeVis (lmax, DMSO): 450 nm; IR (KBr, n, cm1):
3012 (Ar H), 2939 (CH2 str.), 1619 (C]C str.), 1725 (eC]O
str.), 1525 (eN]Ne), 1488, 1115 (]CeOeCH3 str), 1248
(]CeO str.), 759 (1, 2 disubst Ar.), 449 (CoeN), 538
(CoeO); 1H NMR (DMSO-d6, d ppm, 400 MHz): 7.64 (m,
coumarin H-7), 7.41 (m, coumarin H-6), 8.07 (d, coumarin
H-5), 7.49 (d, coumarin H-8), 6.91e7.23 {m, 8H, (C6H4)2},
3.82 {s, 6H, (OCH3)2}; LC-MS (RT,% area); 1.871, 51.04m/
z; 651.0 (M þ 1); Analysis for C33H27CoN4O7: Calcd: C,
60.93; H, 4.18; N, 8.61; Co, 9.06 Found: C, 60.94; H, 4.15; N,
8.65, Co, 9.09%.
Antimicrobial activity
The above newly synthesized 4-HC azo-analogues and
their metal complexes were investigated over different freshly
sub cultured microbial strains, viz. Escherichia coli (MTCC
614), Klebsiella pneumonia (MTCC 109) and Candida albi-
cans (MTCC 3017), that were procured from the Institute of
Microbial Technology and Gene bank (IMTECH), Chan-
digarh, India. Staphylococcus aureus and Cryptococcus neo-
formans were obtained from the University Department of
Pharmaceutical Sciences, Utkal University. Ampicillin and
fluconazole were used as reference antibiotics.
The antimicrobial diffusion test was performed using a
cell suspension of approximately 1.5  106 CFU mL1
employing a McFarland turbidity standard No. 0.5. The
antimicrobial activities of the novel 4-HC analogues (3ae3b)
and the reported complexes (4ae4g) were determined by the
agar well diffusion method using sterile molten nutrient agar
(antibacterial activity) preparations of the compounds and
Sabouraud dextrose agar (antifungal activity) preparations
of compound 4d and their respective complexes.9
Minimum inhibitory concentration (MIC)
A 1 mg mL1 stock solution of each of the synthesized
compounds and reference antibiotic was prepared using
DMF. Further, five different concentrations (500e
31.25 mg mL1) were prepared by the serial dilution method.
The different concentrations for the respective compounds
were loaded into the wells and incubated at 37 C for 18e
24 h. After incubation, the MIC was determined.9
Acute toxicity study
The experiment was carried under the guideline of the
Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA) and approved by the
Institutional Animal Ethical Committee (IAEC), School of
Pharmaceutical Sciences. Siksha ‘O’ Anusandhan Univer-
sity, Bhubaneswar, Odisha, India, with registration number
1171/C/08/CPCSEA and Ref. No. 60/SPS/IAEC/SOAU.
The said synthesized compounds were subjected to an acutePlease cite this article in press as: Sahoo J, Paidesetty SK, Antimicrobial activity
of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumeoral toxicity study to establish their safety dose. Healthy
young female Wister rats that were 8e12 weeks of age were
selected. OECD guideline No. 420 (2000) for the acute oral
toxicity fixed dose procedure of the test compounds (3ae3b
and 4ae4h) was followed. To conduct the sighting study, a
single animal was provided with suspensions of the synthe-
sized compounds having a specific dose, viz. 5 mg, 50 mg,
300 mg and 2000 mg/kg body weight, with the aid of an
intubation canula. A period of 24 h was maintained between
each dosing. In the main study, another 4 animals were
administered 2000 mg/kg. The animals were observed for a
period of 14 days. However, the acute toxic symptoms and
the behavioural changes produced by the test compounds
were observed continuously at an interval of 4 h up to 24 h.
Statistical analysis
The observed data on the zone of inhibitions were sub-
jected to a one way analysis of variance. The mean zone of
inhibition for each compound on each strain was compared
with the reference antibiotic through a Dunnett Post Hoc test
(https://www.statstodo.com/SSizAOV_Pgm.php). The test
of significance was performed at the 5% level of type one
error. The research hypothesis was ‘the zone of inhibition for
the test compound was higher than the reference antibiotics’
against the hypothesis of no difference (null hypotheses),
which states that there is no significant difference between
the zone of inhibition of the test compound and the reference
antibiotics.
Sample size determination
A minimum sample size of five was calculated taking the
probability of type 1 error (d) ¼ 0.05, Power (1-b) ¼ 0.8,
Number of groups ¼ 13 within group SD ¼ 2. However, a
sample size of six has been taken in the study for each
compound against each strain.
Results
The metal complexes of 3-aryl-azo-4-hydroxy coumarin
analogues were synthesized by refluxing different hydro
alcoholic solutions of metal chlorides with 3-(4-chloro
phenyl/4-methoxy phenyl)-azo-4-hydroxy coumarin ana-
logues (Scheme 1) and finally re-crystallized from diethyl
ether. The structures of the prepared compounds are
confirmed by different instrumental methods of analysis. The
physical characteristics of the synthesized compounds are
reported in Table 1. The FT/IR spectra of synthesized
ligands 3a and 3b showed strong vibration bands at 3479e
3445 cm1, 1619e1603 cm1, 1726e1745 cm1, 1298e
1246 cm1 and 1529e1505 cm1 due to presence of
functional groups such as OH str., C]C str., C]O str.,
CeO str. and N]N str., respectively. The strong vibration
bands of compound 3a at 1726, 1619 and 1298 cm1 may
be due to presence of a lactone carbonyl of C]O str., C]
C str. and ]CeO str., respectively, and are illustrated in
Figure 1. The frequencies of all the complexes (4ae4h)
assigned at 1629e1613 cm1, 1729e1721 cm1, 1296e
1248 cm1 and 1529e1524 cm1 correspond to C]C str.,
C]O str., CeO str. and N]N str., respectively. The IRof novel synthesized coumarin based transitional metal complexes, Journal
d.2016.10.004
Scheme 1: Synthesis of coumarin based transitional metal
complexes.
J. Sahoo and S.K. Paidesetty4spectral bands of all metal complexes appearing at 451e441
and 538e531 cm1 are assigned to (MN) and (MO),
respectively. The 1H NMR spectra of the ligands showed a
broad singlet at d 16.81e16.86 ppm towards the presence
of the enolic OH group of 4-hydroxy coumarin. The 1H
NMR spectrum of compound 3b showed a sharp singlet at
d 3.83 ppm corresponding to the proton of eOCH3
(Figure 2). All of the complexes showed signals at a range of
(6.90e7.26)e(7.23e7.37) ppm corresponding to {m, 8H,
(C6H4)2}.
The magnetic susceptibility of the Co(II) complex is
5.09 BM, which is nearer to the reported value for octahedral
symmetry.21 The Ni(II) complex showed a magnetic moment
of 2.94 BM, whereas the Cu(II) complex showed a magnetic
moment of 1.98 BM, suggesting an octahedral geometry.
Compounds 3ae3b act as bidentate ligands by
coordinating to the transitional metal ions through their
azo and enolic hydroxyl moiety. Based upon the study of
magnetic susceptibility values of the complexes, the
probable structure is given in Scheme 1.
The predicted molecular weights of the synthesized com-
pounds were confirmed by LCeMS and the results are
summarized in Table 1. Compound 3a possesses a molecular
ion peak at 301.2 m/z that strongly reveals the predicted
molecular formula C15H9ClN2O3 that is reported in
Figure 4.
The UV spectroscopic analyses of the synthesized ligands
and complexes revealed that complexes 4a and 4e demon-
strated a good bathochromic shift at 463 and 450 nm,
whereas ligands 3a and 3b possessed a l max at 409 and
413 nm, respectively. The solvent effect of the ligands and
their respective complexes are spectrally presented in
Figure 3.
The X-ray diffraction (XRD) technique provides the most
definitive structural information. The study of the XRD
pattern of the synthesized complexes was performed using a
Cu Ka X-ray source and a step of 0.02 (2q) and run at
2q ¼ 2e80 using a Shimadzu XRD 7000 instrument at a
scanning speed of 2.000 (deg/min). Using Origin dataPlease cite this article in press as: Sahoo J, Paidesetty SK, Antimicrobial activity
of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumanalysis software, the structures of the obtained complexes
were interpreted. The pattern and the number of reflections
reported in Figure 5 clearly declared the structural difference
of compounds 4e and 4f.
The results of the antimicrobial activity of the newly
synthesized 3-aryl-azo-4-hydroxy coumarin analogues and
their complexes compared with reference antibiotics (RA)
ampicillin and fluconazole (as antibacterial and antifungal
standard drugs, respectively) expressed in mean  SD are
reported in Table 2. The reported results revealed that
compounds 4a and 4e showed significant antimicrobial
activity in comparison to standard drugs (p < 0.05) against
E. coli, K. pneumonia, S. aureus, C. albicans and
C. neoformans. All compounds except for 4d and 4h
showed significant antibacterial activity against S. aureus.
However, complex 4a showed highest mean zone of
inhibition (mm) against K. pneumonia and C. neoformans,
19  1.1 and 27.5  1.64, respectively. The largest mean
zones of inhibition exhibited by complex 4e against
S. aureus and C. neoformans was 23  2.28 and
28.17  1.72, respectively. The anti-biogram pattern of
compound 3a, 3b and their complexes against different
fungal strains are illustrated in Figure 6. The graphical
representation of complexes 4a and 4e is illustrated in
Figure 7.
The inhibitory property of the compounds was deter-
mined in terms of MIC (mg mL1). The Coþþ complexes of
both the ligands showed the antimicrobial activity against all
the selected strains at MIC level 31.25 mg mL1. All com-
pounds except for 4d and 4h showed a zone of inhibition at
the MIC level 31.25 mg mL1 against C. albicans (Table 3).
No mortality was found for all of the test compounds per
the results of the toxicity study. The synthesized compounds
were safe up to 2000 mg/kg body weight. No significant
change in the body weight of the animals was observed. No
toxic symptoms and gross behavioural changes were
observed in the animals.Discussion
The FT/IR spectra of synthesized ligands 3a and 3b
showed vibrations at 1619e1603 cm1, 1726e1745 cm1,
1298e1246 cm1 and 1529e1505 cm1 corresponding to
C]C str., C]O str., CeO str. and N]N str., respectively,
which were also observed in the synthesized complexes (4ae
4h). The only exception is the bands due to OH str. at 3479e
3445 cm1 exhibited in the ligands that are not observable in
the complexes. In metal Cu(II), Ni(II) Co(II) and Zn(II)
complexes of 3a and 3b, the FT/IR absorption band due to
the hydroxyl group at 4-HC has been diminished and in-
dicates the metal co-ordination of the OH group via depro-
tonation due to liberation of hydrochloric acid. In addition
to these FT/IR spectral data, stretching of the MN and
MO bonds of the complexes, which appear in the higher
frequency wavenumber region in the range 451e441 and
538e531 cm1, also indicates that complexation occurred
through nitrogen and oxygen atoms from the azo-enolic li-
gands.22,23 The 1H NMR spectra of ligands 3a and 3b
showed the enolic OH peak at 16.81 and 16.86 ppm. The
disappearance of the enolic OH group in all the complexes
(4ae4h) may be due to the interaction of metal chloridesof novel synthesized coumarin based transitional metal complexes, Journal
ed.2016.10.004
Table 1: Physical characteristic data of the synthesized 4-hydroxy coumarin analogues and their complexes.
Comps. Substitution M. formula m/z (Calc) m/z (Found) Rf M. P. (C) Colour Yield (%) UV
l max
DMSO
Elemental Analysis Cal. (Found)
C H N
3a 4-Chlorophenyl HL1 C15H9ClN2O3 300.03 301.2 0.7 235e40 Off yellow 91 409 59.91 (59.93) 3.02 (3.04) 9.32 (9.36)
3b 4-Methoxyphenyl Hl2 C16H12N2O4 296.08 297.0 0.8 205e10 Brick red 93 413 64.86 (64.91) 4.08 (4.11) 9.46 (9.43)
Comps. Synthetic
components
M. formula m/z
(Calc)
m/z
(Found)
Rf M. P.
(C)
Colour Yield
(%)
UV
l max
C H N Co Ni Cu Zn
4a Cobalt
complex
of HL1
C32H24ClCoN4O6 654.07 655.0 0.8 245e50 Greenish
yellow
39 463 58.68 (58.64) 3.69 (3.71) 8.55 (8.52) 9.00 (9.03) e e e
4b Nickel
complex
of HL1
C32H24ClN4NiO6 653.07 654.01 0.8 245e50 Light
green
37 440 58.70 (58.68) 3.69 (3.72) 8.56 (8.58) e 8.56 (8.54) 9.63 e
4c Copper
complex
of HL1
C32H24ClCuN4O6 658.07 657.03 0.6 240e45 Light
green
46 432 58.27 (58.31) 3.67 (3.64) 8.49 (8.51) e e 9.63 (9.65) e
4d Zinc
complex
of HL1
C32H24ClN4O6Zn 659.07 661.2 0.9 250e55 Greenish
yellow
33 421 58.11 (58.14) 3.66 (3.64) 8.47 (8.50) e e e 9.89 (9.87)
4e Cobalt
complex
of HL2
C33H27CoN4O7 650.12 651.0 0.7 245e50 Brown 43 450 60.93 (60.94) 4.18 (4.15) 8.61 (8.65) 9.06 (9.09) e e e
4f Nickel
complex
of HL2
C33H27N4NiO7 650.28 651.01 0.5 235e40 Brick
red
39 439 60.95 (60.97) 4.19 (4.17) 8.62 (8.61) e 9.03 (9.11) e e
4g Copper
complex
of HL2
C33H27CuN4O7 654.12 655.03 0.8 245e50 Brown 47 430 60.50 (60.54) 4.15 (4.14) 8.55 (8.59) e e 9.70 (9.71) e
4h Zinc
complex
of HL2
C33H27N4O7Zn 655.12 655.07 0.9 235e40 Brown 41 420 60.33 (60.37) 4.14 (4.16) 8.53 (8.51) e e e 9.96 (9.92)
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Figure 1: FT/IR spectra of 3-((4-chlorophenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (3a).
J. Sahoo and S.K. Paidesetty6with the hydroxyl group of the ligands resulting in
deprotonation and complexation of the ligands to the
metal ions. Ligand 3b shows three identical, similar-
environment protons at 3.83 ppm, which indicates the pres-
ence of an eOCH3 functional group. The good bath-
ochromic shift at 463 and 450 nm exhibited by complexes 4a
and 4e may be due to the attachment of transition metal ion
Coþþ to the respective ligands 3a and 3b. Most of the com-
pounds showed good antimicrobial activity in comparison to
ampicillin. The enhanced antimicrobial activity exhibited byFigure 2: 1H NMR spectra of 4-hydroxy-3-((4-met
Please cite this article in press as: Sahoo J, Paidesetty SK, Antimicrobial activity
of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumcomplexes 4a, 4b, 4e and 4f relative to their ligands against
E. colimay be due to coordination of Coþþ and Niþþ ions to
the respective ligands 3a and 3b. However, complexes 4a and
4e showed considerably enhanced antimicrobial activity
against most of the pathogenic strains relative to their li-
gands. Complexation reduces the polarity of the metal ion by
coordinating with ligands and increases the lipophilicity of
the metals.24 Thus, it facilitates the penetration of the novel
synthesized complexes into the lipoid cell membrane of
microorganisms and inhibits their growth.hoxyphenyl)diazenyl)-2H-chromen-2-one (3b).
of novel synthesized coumarin based transitional metal complexes, Journal
ed.2016.10.004
Figure 4: LCMS of (E)-3-((4-chlorophenyl)diazenyl)-4-hydroxy-2H-chromen-2-one (HL1): (3a).
Figure 3: Solvent effect of the complexes of 3a its metal complexes (plate a) and 3b its metal complexes (plate b) using DMSO.
Figure 5: XRD of 4e and 4f respectively in plate a & b.
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of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.10.004
Table 2: Antimicrobial activity (Zone of inhibition in mm) of the newly synthesized 4-hydroxy coumarin analogues and their complexes
against different microbial strains (Mean ± S.D.) at a concentration of 1 mg mLL1.
Comps. E. colia K. pneumoniab S. aureusc C. albicansd C. neoformanse
3a 17.33  1.63* 16.67  2.42 15.33  2.34 20.67  1.86 25.17  1.84
3b 19.17  2.56* 18.5  3.27 18.83  1.47* 21.83  1.84 26.83  2.64*
4a 19.17  2.4* 19  1.1* 18.33  2.34* 23.67  2.16* 27.5  1.64*
4b 19.17  1.72* 18  1.1 18.83  3.25* 20.83  2.56 14  0.89
4c e 14.17  2.71 17.5  1.64* 18.33  1.63 26.67  1.03*
4d e 11.5  0.84 12.67  1.51 12.5  2.35 11.5  1.64
4e 21.17  2.71* 21.17  4.45* 23  2.28* 25.5  2.07* 28.17  1.72*
4f 23.17  2.23* 19.83  4.07* 21.5  1.76* 22.33  3.27 15.83  1.84
4g e 14.83  2.14 16.83  2.71* 25.17  1.6* 27  2.1*
4h e 12.33  1.51 12.67  2.25 13  3.1 10.83  1.33
RA 12.67  1.51 15.33  1.97 13  1.67 19.33  4.68 24.17  1.94
Results are expressed as the Mean  S.D. (n ¼ 6). The data were analysed by one-way ANOVA followed by Dunnett’s Post Hoc test.
(Statistical significance at *p< 0.05 in comparison to RA (Reference Antibiotic): ampicillin (antibacterial); fluconazole (antifungal));e, No
zone of inhibition; a, Escherichia coli; b, Klebsiella pneumonia; c, Staphylococcus aureus; d, Candida albicans; e, Cryptococcus neoformans.
Figure 6: Antifungal activity of 3a its metal complexes (plate a) and 3b its metal complexes (plate b) against C. neoformans and C. albicans
respectively.
J. Sahoo and S.K. Paidesetty8The limitations of our study include only the investigation
of antimicrobial activity of the novel synthesized complexes
against a few bacterial and fungal strains. Furthermore, it is
necessary to investigate the antimicrobial activities of the
novel complexes against multidrug-resistant microorganisms.Figure 7: Graphical presentation of a
Please cite this article in press as: Sahoo J, Paidesetty SK, Antimicrobial activity
of Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/j.jtumA literature survey revealed that the metal complexes serve as
vehicles for activation of the ligands as principal cytotoxic
species. Therefore, these complexes may be implemented for
the investigation of cytotoxic activity against different cancer
cell lines.ntimicrobial activity of 4d and 4e.
of novel synthesized coumarin based transitional metal complexes, Journal
ed.2016.10.004
Table 3: Minimum inhibitory concentration MIC (mg mLL1) of the newly synthesized 4-hydroxy coumarin analogues and their
complexes against different microbial strains against different microbial strains.
Comps. E. colia K. pneumoniab S. aureusc C. albicansd C. neoformanse
3a 31.25 31.25 250 31.25 31.25
3b 31.25 31.25 31.25 31.25 31.25
4a 31.25 31.25 31.25 31.25 31.25
4b 31.25 31.25 31.25 31.25 250
4c >500 250 31.25 31.25 31.25
4d >500 500 500 500 500
4e 31.25 31.25 31.25 31.25 31.25
4f 31.25 31.25 31.25 31.25 250
4g >500 500 250 31.25 31.25
4h >500 >500 >500 500 >500
a Escherichia coli.
b Klebsiella pneumonia.
c Staphylococcus aureus.
d Candida albicans.
e Cryptococcus neoformans.
Antimicrobial assay of some metal complexes 9Conclusions
In the present work, metal complexes from 3-aryl-azo-4-
hydroxy coumarin analogues were synthesized. The spec-
tral characterization of the complexes confirmed their
structural environment. It is suggested that the pronounced
antimicrobial activity executed by the complexes (4a and 4e)
relative to their ligands permits their recommendation as a
new chemical class of antimicrobial agents.Conflict of interest
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